AASLD2024-话题@MedSci

#AASLD2024#

0篇内容 | 342人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2242284, encodeId=0e8a2242284dc, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】高灵敏HBcrAg检测或可有效预测HBeAg阴性慢乙肝患者的治疗疗效和疾病进展, objectType=article, longId=855247, objectId=73d685524ef5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719545882221_8538692.jpg, objectUrl=/article/show_article.do?id=73d685524ef5, replyNumber=0, likeNumber=25, createdTime=2024-12-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=73d685524ef5, moduleTitle=【AASLD2024速递】高灵敏HBcrAg检测或可有效预测HBeAg阴性慢乙肝患者的治疗疗效和疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73d685524ef5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2242281, encodeId=887d2242281dd, content=<a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】乙肝新药ALG-000184表现出极佳的抗HBV病毒活性, objectType=article, longId=854048, objectId=b4bf85404871, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241127/1732690218078_8538692.jpg, objectUrl=/article/show_article.do?id=b4bf85404871, replyNumber=0, likeNumber=19, createdTime=2024-12-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=b4bf85404871, moduleTitle=【AASLD2024速递】乙肝新药ALG-000184表现出极佳的抗HBV病毒活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4bf85404871)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2241382, encodeId=437e224138206, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】张文宏教授团队：“绿洲”项目多项亚组分析数据获2024年AASLD年会摘要收录, objectType=article, longId=854367, objectId=327085436e02, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719539714497_5579292.jpg, objectUrl=/article/show_article.do?id=327085436e02, replyNumber=0, likeNumber=20, createdTime=2024-12-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=327085436e02, moduleTitle=【AASLD2024速递】张文宏教授团队：“绿洲”项目多项亚组分析数据获2024年AASLD年会摘要收录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=327085436e02)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2241399, encodeId=d8412241399ec, content=<a href='/topic/show?id=2a3f2343353' target=_blank style='color:#2F92EE;'>#乙肝新药#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】PD-L1抑制剂类乙肝新药研究进展汇总, objectType=article, longId=854531, objectId=15b985453105, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240703/1719970229062_92910.png, objectUrl=/article/show_article.do?id=15b985453105, replyNumber=0, likeNumber=21, createdTime=2024-12-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=15b985453105, moduleTitle=【AASLD2024速递】PD-L1抑制剂类乙肝新药研究进展汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15b985453105)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2241083, encodeId=f6e622410838e, content=<a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a> <a href='/topic/show?id=cde81220e0c2' target=_blank style='color:#2F92EE;'>#乙肝筛查#</a>, objectTitle=【AASLD2024】扩大基于医院的乙肝筛查和管理方案可加快中国乙肝的消除，并具有成本效益, objectType=article, longId=853525, objectId=aefb853525f0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241127/1732690218078_8538692.jpg, objectUrl=/article/show_article.do?id=aefb853525f0, replyNumber=0, likeNumber=19, createdTime=2024-12-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=aefb853525f0, moduleTitle=【AASLD2024】扩大基于医院的乙肝筛查和管理方案可加快中国乙肝的消除，并具有成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aefb853525f0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2241078, encodeId=1e4522410e8e6, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】数据更新：实施综合干预策略（GATE）计划，慢乙肝患者的抗病毒治疗率显著提升, objectType=article, longId=853772, objectId=44e6853e72a1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719545882221_8538692.jpg, objectUrl=/article/show_article.do?id=44e6853e72a1, replyNumber=0, likeNumber=24, createdTime=2024-12-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=44e6853e72a1, moduleTitle=【AASLD2024速递】数据更新：实施综合干预策略（GATE）计划，慢乙肝患者的抗病毒治疗率显著提升, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44e6853e72a1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239819, encodeId=d68e2239819c8, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=8ef211125572' target=_blank style='color:#2F92EE;'>#MASLD#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】MASLD可能降低慢乙肝患者的肝细胞癌、肝功能失代偿和死亡风险, objectType=article, longId=852531, objectId=7f17852531d4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867593143_4754896.jpeg, objectUrl=/article/show_article.do?id=7f17852531d4, replyNumber=0, likeNumber=31, createdTime=2024-11-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f17852531d4, moduleTitle=【AASLD2024速递】MASLD可能降低慢乙肝患者的肝细胞癌、肝功能失代偿和死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f17852531d4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239844, encodeId=da222239844b5, content=<a href='/topic/show?id=890e8438e3e' target=_blank style='color:#2F92EE;'>#脂肪肝#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】合并脂肪肝对慢乙肝患者抗病毒治疗疗效影响的争议, objectType=article, longId=853117, objectId=39c185311ec3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=39c185311ec3, replyNumber=0, likeNumber=28, createdTime=2024-11-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39c185311ec3, moduleTitle=【AASLD2024速递】合并脂肪肝对慢乙肝患者抗病毒治疗疗效影响的争议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39c185311ec3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239624, encodeId=f1e4223962463, content=<a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a> <a href='/topic/show?id=6aa3121804d0' target=_blank style='color:#2F92EE;'>#DF-006#</a>, objectTitle=【AASLD2024速递】新型ALPK1激动剂DF-006的I期药效学数据公布, objectType=article, longId=852532, objectId=270885253246, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-using-smartphone-app-in-hospital-office-PEMB8JL.jpg, objectUrl=/article/show_article.do?id=270885253246, replyNumber=0, likeNumber=22, createdTime=2024-11-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=270885253246, moduleTitle=【AASLD2024速递】新型ALPK1激动剂DF-006的I期药效学数据公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=270885253246)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239623, encodeId=eede223962338, content=<a href='/topic/show?id=2a3f2343353' target=_blank style='color:#2F92EE;'>#乙肝新药#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】乙肝新药Xalnesiran II期研究48周随访结果公布：获得HBsAg清除后再停用NA更安全, objectType=article, longId=852533, objectId=a746852533e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240521/1716259408769_5579292.jpg, objectUrl=/article/show_article.do?id=a746852533e2, replyNumber=0, likeNumber=25, createdTime=2024-11-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a746852533e2, moduleTitle=【AASLD2024速递】乙肝新药Xalnesiran II期研究48周随访结果公布：获得HBsAg清除后再停用NA更安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a746852533e2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239524, encodeId=244622395241f, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】多项研究报道全球慢乙肝患者中超过40%处于不确定期，疾病进展风险高，建议抗病毒治疗, objectType=article, longId=852973, objectId=66678529e33b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241120/1732096450891_8538692.jpg, objectUrl=/article/show_article.do?id=66678529e33b, replyNumber=0, likeNumber=21, createdTime=2024-11-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66678529e33b, moduleTitle=【AASLD2024速递】多项研究报道全球慢乙肝患者中超过40%处于不确定期，疾病进展风险高，建议抗病毒治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66678529e33b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239257, encodeId=c2cd223925e6b, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】任红教授团队：慢乙肝患者接受抗病毒治疗可有效减少HBV整合事件, objectType=article, longId=852535, objectId=bdf385253539, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719493607463_8538692.png, objectUrl=/article/show_article.do?id=bdf385253539, replyNumber=0, likeNumber=25, createdTime=2024-11-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=bdf385253539, moduleTitle=【AASLD2024速递】任红教授团队：慢乙肝患者接受抗病毒治疗可有效减少HBV整合事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdf385253539)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239256, encodeId=bb5e223925645, content=<a href='/topic/show?id=018880e834b' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α-2b#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】聚乙二醇干扰素α-2b间歇治疗相比连续治疗的安全性更好, objectType=article, longId=852534, objectId=04cf85253450, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241107/1730967184313_8538692.jpg, objectUrl=/article/show_article.do?id=04cf85253450, replyNumber=0, likeNumber=26, createdTime=2024-11-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=04cf85253450, moduleTitle=【AASLD2024速递】聚乙二醇干扰素α-2b间歇治疗相比连续治疗的安全性更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04cf85253450)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2238672, encodeId=f95c22386e24f, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】慢乙肝患者积极抗病毒治疗可显著改善肝组织学进展, objectType=article, longId=851523, objectId=f1e3851523a1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240512/1715508384935_5579292.jpg, objectUrl=/article/show_article.do?id=f1e3851523a1, replyNumber=0, likeNumber=32, createdTime=2024-11-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f1e3851523a1, moduleTitle=【AASLD2024速递】慢乙肝患者积极抗病毒治疗可显著改善肝组织学进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1e3851523a1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2238289, encodeId=1f0922382892c, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=2024 AASLD | STRIDE方案治疗Child-Pugh B级uHCC的真实世界探索, objectType=article, longId=851547, objectId=4a1985154e18, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719539714497_5579292.jpg, objectUrl=/article/show_article.do?id=4a1985154e18, replyNumber=0, likeNumber=34, createdTime=2024-11-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=4a1985154e18, moduleTitle=2024 AASLD | STRIDE方案治疗Child-Pugh B级uHCC的真实世界探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a1985154e18)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2237343, encodeId=09e0223e343be, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】RCT研究：非活动性HBsAg携带状态人群基于聚乙二醇干扰素α治疗48周的HBsAg清除率近40%, objectType=article, longId=850137, objectId=537285013e3b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=537285013e3b, replyNumber=0, likeNumber=39, createdTime=2024-11-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=537285013e3b, moduleTitle=【AASLD2024速递】RCT研究：非活动性HBsAg携带状态人群基于聚乙二醇干扰素α治疗48周的HBsAg清除率近40%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=537285013e3b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2234368, encodeId=da07223436876, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=7dd51e788b8' target=_blank style='color:#2F92EE;'>#Treg细胞#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】Treg细胞可预测PegIFNα-2b治疗的HBsAg清除, objectType=article, longId=849225, objectId=290484922582, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240623/1719152329615_5579292.png, objectUrl=/article/show_article.do?id=290484922582, replyNumber=0, likeNumber=35, createdTime=2024-10-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=290484922582, moduleTitle=【AASLD2024速递】Treg细胞可预测PegIFNα-2b治疗的HBsAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=290484922582)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2233399, encodeId=60f1223339988, content=<a href='/topic/show?id=b97885350d' target=_blank style='color:#2F92EE;'>#HBV感染#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】荟萃分析：HBV感染对辅助生殖的影响, objectType=article, longId=848711, objectId=d132848e115a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240703/1719979466467_5579292.png, objectUrl=/article/show_article.do?id=d132848e115a, replyNumber=0, likeNumber=32, createdTime=2024-10-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d132848e115a, moduleTitle=【AASLD2024速递】荟萃分析：HBV感染对辅助生殖的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d132848e115a)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

HBV感染 AASLD2024

2024-10-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #AASLD2024#

【AASLD2024速递】高灵敏HBcrAg检测或可有效预测HBeAg阴性慢乙肝患者的治疗疗效和疾病进展

2024-12-13发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#乙肝# #AASLD2024#

【AASLD2024速递】乙肝新药ALG-000184表现出极佳的抗HBV病毒活性

2024-12-13发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #AASLD2024#

【AASLD2024速递】张文宏教授团队：“绿洲”项目多项亚组分析数据获2024年AASLD年会摘要收录

2024-12-08发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#乙肝新药# #AASLD2024#

【AASLD2024速递】PD-L1抑制剂类乙肝新药研究进展汇总

2024-12-08发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#AASLD2024# #乙肝筛查#

【AASLD2024】扩大基于医院的乙肝筛查和管理方案可加快中国乙肝的消除，并具有成本效益

2024-12-06发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #AASLD2024#

【AASLD2024速递】数据更新：实施综合干预策略（GATE）计划，慢乙肝患者的抗病毒治疗率显著提升

2024-12-06发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #MASLD# #AASLD2024#

【AASLD2024速递】MASLD可能降低慢乙肝患者的肝细胞癌、肝功能失代偿和死亡风险

2024-11-28

梅斯管理员 (审核中...)

前往app查看评论内容

#脂肪肝# #慢乙肝# #AASLD2024#

【AASLD2024速递】合并脂肪肝对慢乙肝患者抗病毒治疗疗效影响的争议

2024-11-28

梅斯管理员 (审核中...)

前往app查看评论内容

#AASLD2024# #DF-006#

【AASLD2024速递】新型ALPK1激动剂DF-006的I期药效学数据公布

2024-11-27

梅斯管理员 (审核中...)

前往app查看评论内容

#乙肝新药# #AASLD2024#

【AASLD2024速递】乙肝新药Xalnesiran II期研究48周随访结果公布：获得HBsAg清除后再停用NA更安全

2024-11-27

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #AASLD2024#

【AASLD2024速递】多项研究报道全球慢乙肝患者中超过40%处于不确定期，疾病进展风险高，建议抗病毒治疗

2024-11-27

梅斯管理员 (审核中...)